Toxicity profile of interferon alfa-2b in children: A prospective evaluation
- 1 December 1999
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 135 (6) , 782-785
- https://doi.org/10.1016/s0022-3476(99)70104-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancyThe Journal of Pediatrics, 1998
- Therapeutic efficacy of interferon alfa-2b in infants with life-threatening giant hemangiomas.Archives of Dermatology, 1997
- Recombinant interferon alfa-2b in the treatment of vision-threatening capillary hemangiomas in childhoodJournal of American Association for Pediatric Ophthalmology and Strabismus, 1997
- Successful Treatment of Infantile Hemangiomas with Interferon-α-2bJournal of Pediatric Hematology/Oncology, 1997
- Interferon- Therapy for Chronic Hepatitis B in Children: A Meta-AnalysisClinical Infectious Diseases, 1996
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of InfancyNew England Journal of Medicine, 1992
- Treatment of childhood angiomatous diseases with recombinant interferon alfa-2aThe Journal of Pediatrics, 1991
- TREATMENT OF HAEMANGIOENDOTHELIOMAS WITH ALPHA INTERFERONThe Lancet, 1989
- Neurologic Sequelae Following Interferon Therapy of Juvenile Laryngeal PapillomaActa Paediatrica, 1988